XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net income (loss) $ 1,093 $ (374)
Adjustments to reconcile net income to cash flow from operating activities:    
Depreciation and amortization 16,552 14,828
Amortization of deferred financing costs 364 361
Stock compensation 3,326 2,627
Casualty losses 359  
Amortization related to derivative instruments 302 280
Changes in assets and liabilities:    
Other assets (90) (875)
Accounts payable and accrued expenses (1,321) (5,171)
Accrued interest payable (88) (59)
Other liabilities 141 67
Cash flow provided by operating activities 20,638 11,684
Cash flows from investing activities:    
Acquisition of real estate properties (365) (50,598)
Capital expenditures (6,916) (8,572)
Cash flow used in investing activities (7,281) (59,170)
Cash flows from financing activities:    
Proceeds from unsecured credit facility and term loans 9,500 65,501
Mortgage principal repayments (7,918) (1,843)
Payments for deferred financing costs   (50)
Proceeds from issuance of common stock, net (59) 49,764
Distributions on common stock (12,450) (16,493)
Distributions to noncontrolling interests (81) (160)
Repurchase of shares related to equity award tax withholding (2,862) (1,490)
Cash flow (used in) provided by financing activities (13,870) 95,229
Net change in cash and cash equivalents, and restricted cash (513) 47,743
Cash and cash equivalents, and restricted cash, beginning of period 13,615 14,433
Cash and cash equivalents, and restricted cash, end of the period 13,102 62,176
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheet    
Cash and cash equivalents 8,653 57,436
Restricted cash 4,449 4,740
Cash and cash equivalents, and restricted cash, end of the period $ 13,102 $ 62,176